Risk factors for the development of bronchopulmonary dysplasia: the role of antenatal infection and inflammation

References

• Johnson AH, Peacock JL, Greenough A et al; for the United Kingdom Oscillation Study Group. High frequency oscillatory ventilaton for the prevention of chronic lung disease of prematurity. N. Engl. J. Med.347(9), 633–642 (2002).
   PubMed Web of Science ®Google Scholar
• Jobe AH, Bancalari E. NICHD/NHLSI/ORD Workshop summary. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med.163, 1723–1729 (2001).
   PubMedGoogle Scholar
• Ellsbury DL, Acarregui MJ, McGuiness GA, Klein JM. Variability in the use of supplemental oxygen for bronchopulmonary dysplasia. J. Pediatr.149, 247–249 (2002).
   Google Scholar
• Sharma A, Greenough A. Survey of neonatal respiratory support strategies. Acta Pediatr. (2007) (In Press).
   Google Scholar
• Walsh MC, Yao Q, Gettner P et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics114, 1305–1311 (2004).
   PubMed Web of Science ®Google Scholar
• Greenough A, Hird MF, Gamsu HR. Home oxygen therapy following neonatal intensive care. Early Hum. Dev.26, 29–35 (1991).
   Google Scholar
• Greenough A, Alexander J, Burgess S et al. Preschool health care utilisation related to home oxygen status. Arch. Dis. Child Fetal. Neonatal Ed.91(5), F337–F341 (2006).
   Google Scholar
• Greenough A, Alexander J, Burgess S et al. Health care utilisation of prematurely born, preschool children related to hospitalisation for RSV infection. Arch. Dis. Child89, 673–678 (2004).
   Google Scholar
• Greenough A, Alexander J, Burgess S et al. Home oxygen status on rehospitalisation and primary care requirements of chronic lung disease infants. Arch. Dis. Child86, 40–43 (2002).
   Google Scholar
• Baraldi E, Filippone M, Trevisanuto D, Zanardo V, Zacchello F. Pulmonary function until two years of life in infants with bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med.155, 149–155 (1997).
   PubMed Web of Science ®Google Scholar
• Filippone M, Sartor M Zachello F, Baraldi E. Flow limitation in infants with bronchopulmonary dysplasia and respiratory function at school age. Lancet361, 753–754 (2003).
   PubMed Web of Science ®Google Scholar
• Hofhuis W, Huysman MWA, van der Wiel EC et al. Worsening of Vmax/FRC in infants with chronic lung disease in the first year of life: a more favourable outcome after high frequency oscillation ventilation. Am. J. Respir. Crit. Care Med.166, 1539–1543 (2002).
   PubMed Web of Science ®Google Scholar
• Koumbourlis AC, Motoyama EK, Mutich RL, Mallory GB, Walczak SA, Fertal K. Longitudinal follow up of lung function from childhood to adolescence in prematurely born patients with neonatal chronic lung disease. Pediatr. Pulmonol.21, 28–34 (1996).
   PubMedGoogle Scholar
• Northway WH Jr, Rosan RC, Porter DY. Pulmonary disease following respiratory therapy of hyaline membrane disease. N. Engl. J. Med.276, 357–368 (1967).
   PubMed Web of Science ®Google Scholar
• Vrijlandt EJ, Gerritsen J, Marike Boezen H, Duiverman EJ; The Dutch POPS-19 Collaborative Study Group. Gender differences in respiratory symptoms in 19 year old adults born preterm. Respir. Res.6, 117 (2005).
   PubMed Web of Science ®Google Scholar
• Rojas MA, Gonzalez A, Bancalari E et al. Changing trends in the epidemiology and pathogenesis of chronic lung disease. J. Pediatr.126, 605–610 (1995).
   PubMed Web of Science ®Google Scholar
• Husain AN, Siddiqui NH, Stocker JT. Pathology of arrested acinar development in postsurfactant bronchopulmonary dysplasia. Hum. Pathol.29, 710–717 (1998).
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Tuder RM, Taraseviciene-Stewart L et al. Inhibition of VEGF receptors causes lung cell apoptosis and emphysema. J. Clin. Invest.106, 1311–1319 (2000).
   PubMed Web of Science ®Google Scholar
• Tang JR, Markham NE, Lin YJ et al. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Am. J. Physiol. Lung Cell Mol. Physiol.287, L344–L351 (2004).
   PubMed Web of Science ®Google Scholar
• Greenough A, Limb E, Marston L, Marlow N, Calvert S, Peacock J. Risk factors for respiratory morbidity in infancy following very premature birth. Arch. Dis. Child90(4), F320–F323 (2005).
   Google Scholar
• Thomas M, Rafferty G, Limb E et al. Pulmonary function at follow up of very preterm infants from the UK oscillation study. Am. J. Respir. Crit. Care Med.169, 868–872 (2004).
   PubMed Web of Science ®Google Scholar
• Jobe AH. The new BPD: an arrest of lung development. Pediatr. Res.46, 641–643 (1999).
   PubMed Web of Science ®Google Scholar
• Massaro GD, Massaro D. Formation of pulmonary alveoli and gas exchange surface area: quantitation and regulation. Annu. Rev. Physiol.58, 73–92 (1996).
   PubMed Web of Science ®Google Scholar
• Makri V, Hospes B, Stoll-Becker S, Borkhardt A, Gortner L. Polymorphisms of surfactant protein B encoding gene: modifiers of the course of neonatal respiratory distress. Eur. J. Pediatr.161, 604–608 (2002).
   PubMed Web of Science ®Google Scholar
• Hallman M, Haataja K. Genetic influences and neonatal lung disease. Semin. Neonatol.8, 19–27 (2003).
   PubMedGoogle Scholar
• Harding D, Dhamrait S, Marlow N et al. Angiotensin-converting enzyme DD genotype is associated with worse perinatal cardiorespiratory adaptation in preterm infants. J. Pediatr.143, 746–749 (2003).
   Google Scholar
• Nadya S, Kazzi J, Quasney MW. Deletion allele of angiotensin-converting enzyme is associated with increased risk and severity of bronchopulmonary dysplasia. J. Pediatr.147, 818–822 (2005).
   Google Scholar
• Yanamandra K, Loggins J, Baier RJ. The angiotensin converting enzyme insertion/deletion polymorphism is not associated with an increased risk of death or bronchopulmonary dysplasia in ventilated very low birth weight infants. BMC Pediatrics4, 26 (2004).
   PubMedGoogle Scholar
• Gonzalez A, Sosenko IRS, Chandar J et al. Influence of infection on patent ductus arteriosus and chronic lung disease in premature infants weighing 1000 g or less. J. Pediatr.128, 470–478 (1996).
   PubMed Web of Science ®Google Scholar
• Van Marter LJ, Leviton A, Allred EN et al. Hydration during the first days of life and the risk of bronchopulmonary dysplasia in low birth weight infants. J. Pediatr.116, 942–949 (1990).
   PubMed Web of Science ®Google Scholar
• Kavvadia V, Greenough A, Dimitriou G, Hooper R. Randomized trial of fluid restriction in ventilated very low birthweight infants. Arch. Dis. Child.83, F91–F96 (2000).
   Google Scholar
• Kavvadia V, Greenough A, Dimitriou G, Forsling ML. A comparison of arginine vasopressin levels and fluid balance in the perinatal period in infants who did and did not develop chronic oxygen dependency. Biol. Neonat.78, 86–91 (2000).
   Google Scholar
• Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen saturation targets and outcomes in extremely preterm infants. N. Engl. J. Med.349, 959–967 (2003).
   PubMed Web of Science ®Google Scholar
• The STOP-ROP Multicentre Study Group. Supplemental therapeutic oxygen for pre-threshold retinopathy of prematurity (STOP-ROP). A randomised controlled trial 1: primary outcomes. Pediatrics105, 295–310 (2000).
   PubMed Web of Science ®Google Scholar
• Kraybill EN, Runyan DK, Bose CL et al. Risk factors for chronic lung disease in infants with birth weights of 751 to 1000 grams. J. Pediatr.115, 115–120 (1989).
   PubMed Web of Science ®Google Scholar
• Bjorklund LJ, Ingimarsson J, Curstedt T et al. Manual ventilation with a few large breaths at birth compromises the therapeutic effect of subsequent surfactant replacement in immature lungs. Pediatr. Res.42, 348–355 (1997).
   PubMed Web of Science ®Google Scholar
• Wada K, Jobe AH, Ikegami M. Tidal volume effects on surfactant treatment responses with the initiation of ventilation in preterm lambs. J. Appl. Physiol.83, 1054–1061 (1997).
   Google Scholar
• Hernandez LA, Peevy KJ, Moise AA, Parker JC. Chest wall restriction limits high airway pressure induced lung injury in young rabbits. J. Appl. Physiol.66, 2364–2368 (1989).
   PubMed Web of Science ®Google Scholar
• Wang EEL, Ohlsson A, Kellner JD. Association of ureaplasma urealyticum colonization with chronic lung disease of prematurity: results of a meta-analysis. J. Pediatr.127, 640–644 (1995).
   PubMed Web of Science ®Google Scholar
• Wang EE, Cassell GH, Sanchez PJ, Regan JA, Payne NR, Liu PP. Ureaplasma urealyticum and chronic lung disease of prematurity: critical appraisal of the literature on causation. Clin. Infect. Dis.17, S112–S116 (1993).
   Google Scholar
• Fujimura M, Takeuchi T, Ando M et al. Elevated immunoglobulin M levels in low birthweight infants with chronic respiratory insufficiency. Early Hum. Dev.9, 27–32 (1983).
   Google Scholar
• Fujimura M, Takeuchi T, Kitajima H, Nakayama M. Chorioamnionitis and serum IgM in Wilson Mikity syndrome. Arch. Dis. Child64, 1379–1383 (1989).
   Google Scholar
• Fujimura M, Kitajima H, Nakayama M. Increased leukocyte elastase of the tracheal aspirate at birth and neonatal pulmonary emphysema. Pediatrics96, 564–569 (1993).
   Google Scholar
• Watterberg KL, Demers LM, Scott SM et al. Chorioamnionitis and early lung inflammation in infants in whom bronchopulmonary dysplasia develops. Pediatrics97, 210–215 (1996).
   PubMed Web of Science ®Google Scholar
• Van Marter LJ, Ammann O, Allred EN et al. Chorioamnionitis, mechanical ventilation and postnatal sepsis as modulators of chronic lung disease in preterm infants. J. Pediatr.140, 171–176 (2002).
   PubMed Web of Science ®Google Scholar
• Kallapur SG, Willet KE, Jobe AH et al. Intra-amniotic endotoxin: chorioamnionitis precedes lung maturation in preterm lambs. Am. J. Physiol.280, L527–L536 (2001).
   PubMed Web of Science ®Google Scholar
• Kramer BW, Moss TJ, Willet K et al. Dose and time response after intraamniotic endotoxin in preterm lambs. Am. J. Respir. Crit. Care Med.164, 982–988 (2001).
   PubMed Web of Science ®Google Scholar
• Kallapur SG, Nitsos I, Moss TJM et al. Chronic endotoxin exposure does not cause sustained structural abnormalities in the fetal sheep lungs. Am. J. Physiol. Lung Cell Mol. Physiol.288, L966–L974 (2005).
   PubMed Web of Science ®Google Scholar
• Kallapur SG, Moss TJ, Ikegami M, Jasman RI, Newnham JP, Jobe AH. Recruited inflammatory cells mediate endotoxin induced lung maturation in preterm fetal lambs. Am. J. Respir. Crit. Care Med.172, 1315–1321 (2005).
   PubMed Web of Science ®Google Scholar
• Kramer BW, Joshi SN, Moss TJM et al. Endotoxin induced maturation of monocytes in preterm fetal sheep lung. Am. J. Physiol. Lung Cell Mol. Physiol.293, L345–L353 (2007).
   PubMed Web of Science ®Google Scholar
• Kramer BW, Ikegami M, Moss TJM, Nitsos I, Newnham JP, Jobe AH. Endotoxin induced chorioamnionitis modulates innate immunity of monocytes in preterm sheep. Am. J. Respir. Crit. Care Med.171, 73–77 (2005).
   PubMed Web of Science ®Google Scholar
• Bartram U, Speer CP. The role of transforming growth factor-β in lung development and disease. Chest125, 754–765 (2004).
   PubMed Web of Science ®Google Scholar
• Gauldie J, Galt T, Bonniaud P et al. Transfer of the active form of transforming growth factor-β 1 gene to newborn rat lung induces changes consistent with bronchopulmonary dysplasia. Am. J. Pathol.163, 2575–2584 (2003).
   PubMed Web of Science ®Google Scholar
• Kunzmann S, Speer C, Jobe AH et al. Antenatal inflammation induced TGF-β 1 but suppressed CTGF in preterm lungs. Am. J. Physiol. Lung Cell Mol. Physiol.292, L223–L231 (2007).
   PubMed Web of Science ®Google Scholar
• Jobe AH, Newnham JP, Willet KE et al. Endotoxin induced lung maturation in preterm lambs is not mediated by cortisol. Am. J. Respir. Crit. Care Med.162, 1656–1661 (2000).
   PubMed Web of Science ®Google Scholar
• Bry K, Lappalainen U, Hallman M. Intramniotic interleukin-1 accelerates surfactant protein synthesis in fetal rabbits and improves lung stability after premature birth. J. Clin. Invest.99, 2992–2999 (1997).
   PubMed Web of Science ®Google Scholar
• Sosenko IR, Kallapur SG, Nitsos I et al. IL-1α causes lung inflammation and maturation by direct effects on preterm fetal lamb lungs. Pediatr. Res.60(3), 294–298 (2006).
   PubMed Web of Science ®Google Scholar
• Willet KE, Jobe AH, Ikegami M, Newnham J, Brennan S, Sly PD. Antenatal endotoxin and glucocorticoid effects on lung morphometry in preterm lambs. Pediatr. Res.48, 782–788 (2000).
   PubMed Web of Science ®Google Scholar
• Burri PH. The postnatal growth of the rat lung. III. Morphology. Anat. Rec.180, 77–98 (1975).
   Google Scholar
• Kauffman SL, Burri PH, Weibel ER. The postnatal growth of the rat lung II. Autoradiography. Anat. Rec.180, 63–76 (1974).
   PubMedGoogle Scholar
• Burri PH. Postnatal development and growth. In: The Lung: Scientific Foundations.Crystal RG, West JB, Weibel ER, Barnes PJ (Eds). Lippincott Raven, PA, USA 1013–1026 (1997).
   Google Scholar
• Kallapur SG, Kramer BW, Moss TJ et al. Maternal glucocorticoids increase endotoxin-induced lung inflammation in preterm lambs. Am. J. Physiol. Lung Cell Mol. Physiol.284, L633–L642 (2003).
   PubMed Web of Science ®Google Scholar
• Gomez R, Romero R, Ghezzi F, Yoon B, Mazor M, Berry S. The fetal inflammatory response syndrome. Am. J. Obstet. Gynecol.179, 194–202 (1998).
   PubMed Web of Science ®Google Scholar
• Romero R, Gomez R, Ghezzi F et al. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am. J. Obstet. Gynecol.179, 186–193 (1998).
   PubMed Web of Science ®Google Scholar
• Watts D, Kronh M, Hillier S, Eschenbach D. The association of occult amniotic fluid infection with gestational age and neonatal outcome among women in preterm labour. Obstet. Gynecol.79, 351–357 (1992).
   PubMed Web of Science ®Google Scholar
• Wenstrom KD, Andrews WW, Hauth JC et al. Elevated second-trimester amniotic fluid interleukin-6 levels predict preterm delivery. Am. J. Obstet. Gynecol.178(3), 546–550 (1998).
   PubMed Web of Science ®Google Scholar
• Duggan PJ, Maalouf EF, Watts TL et al. Intrauterine T-cell activation and increased proinflammatory cytokine concentrations in preterm infants with cerebral lesions. Lancet358(9294), 1699–1700 (2001).
   PubMed Web of Science ®Google Scholar
• Yoon BH, Romero R, Jun JK et al. Amniotic fluid cytokines (interleukin-6, tumor necrosis factor-α, interleukin-1 β, and interleukin-8) and the risk for the development of bronchopulmonary dysplasia. Am. J. Obstet. Gynecol.177(4), 825–830 (1997).
   PubMed Web of Science ®Google Scholar
• Jobe AH. Antenatal factors and the development of bronchopulmonary dysplasia. Sem. Neonatol.8, 9–17 (2003).
   PubMedGoogle Scholar
• Crowley P. Antenatal corticosteroid therapy: a metanalysis of the randomized trials 1972–1994. Am. J. Obstet. Gynecol.173, 322–335 (1995).
   PubMed Web of Science ®Google Scholar
• Elimian A, Verma U, Beneck D, Cipriano R, Visintainer P, Tejani N. Histologic chorioamnionitis, antenatal steroids, and perinatal outcomes. Obstet. Gynecol.96, 333–336 (2000).
   PubMed Web of Science ®Google Scholar
• Harding JE, Pang J, Knight DB, Liggins GC. Do antenatal corticosteroids help in the setting of preterm rupture of membranes. Am. J. Obstet. Gynecol.184, 131–139 (2001).
   PubMed Web of Science ®Google Scholar